Cabaletta Bio, Inc. (CABA)

Cabaletta Bio Statistics

Total Valuation

Cabaletta Bio has a market cap or net worth of $84.30 million. The enterprise value is -$19.27 million.

Market Cap	84.30M
Enterprise Value	-19.27M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Cabaletta Bio has 53.35 million shares outstanding. The number of shares has increased by 11.24% in one year.

Current Share Class	53.35M
Shares Outstanding	53.35M
Shares Change (YoY)	+11.24%
Shares Change (QoQ)	+1.22%
Owned by Insiders (%)	2.84%
Owned by Institutions (%)	61.12%
Float	46.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.66
P/TBV Ratio	0.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.24.

Current Ratio	3.96
Quick Ratio	3.88
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-128.83

Financial Efficiency

Return on equity (ROE) is -73.85% and return on invested capital (ROIC) is -44.13%.

Return on Equity (ROE)	-73.85%
Return on Assets (ROA)	-41.37%
Return on Invested Capital (ROIC)	-44.13%
Return on Capital Employed (ROCE)	-102.36%
Revenue Per Employee	n/a
Profits Per Employee	-$772,927
Employee Count	164
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -77.96% in the last 52 weeks. The beta is 2.79, so Cabaletta Bio's price volatility has been higher than the market average.

Beta (5Y)	2.79
52-Week Price Change	-77.96%
50-Day Moving Average	1.65
200-Day Moving Average	2.56
Relative Strength Index (RSI)	40.38
Average Volume (20 Days)	2,925,224

Short Selling Information

The latest short interest is 6.47 million, so 12.12% of the outstanding shares have been sold short.

Short Interest	6.47M
Short Previous Month	6.20M
Short % of Shares Out	12.12%
Short % of Float	14.04%
Short Ratio (days to cover)	1.92

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-134.25M
Pretax Income	-89.98M
Net Income	-126.76M
EBITDA	-132.44M
EBIT	-134.25M
Earnings Per Share (EPS)	-$2.57

Balance Sheet

The company has $131.83 million in cash and $28.79 million in debt, giving a net cash position of $103.04 million or $1.93 per share.

Cash & Cash Equivalents	131.83M
Total Debt	28.79M
Net Cash	103.04M
Net Cash Per Share	$1.93
Equity (Book Value)	121.55M
Book Value Per Share	2.40
Working Capital	100.61M

Cash Flow

In the last 12 months, operating cash flow was -$95.04 million and capital expenditures -$2.18 million, giving a free cash flow of -$97.22 million.

Operating Cash Flow	-95.04M
Capital Expenditures	-2.18M
Free Cash Flow	-97.22M
FCF Per Share	-$1.82

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cabaletta Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.24%
Shareholder Yield	-11.24%
Earnings Yield	-151.33%
FCF Yield	-116.06%

Analyst Forecast

The average price target for Cabaletta Bio is $18.88, which is 1,094.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.88
Price Target Difference	1,094.94%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-24.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1